Malcolm D. Mason

Cardiff University — United Kingdom

Medicine · Health Sciences

91h-index46.7kcitations446works40.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(172), Prostate Cancer Diagnosis and Treatment(119), Bladder and Urothelial Cancer Treatments(43), Extracellular vesicles in disease(33), Radiopharmaceutical Chemistry and Applications(33)

Publications443 total

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality
JAMA·2024· 81 citedOpen Access
Correction: YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells
Journal of Translational Medicine·2024Open Access
Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against
British Journal of Cancer·2023· 42 citedOpen Access
RWD123 Machine Learning (ML) Applied to Real-World Data to Guide Prescription of Immune-Therapies in Metastatic Melanoma: A Pilot Study
Value in Health·2023Open Access
Contents
Radiotherapy and Oncology·2023Open Access
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
The Lancet Oncology·2023· 85 citedOpen Access
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review
European Urology·2023· 25 citedOpen Access
Supplementary Figure 1 from Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells—A Key Role for Heat-Shock Protein 70 and Receptor CD91
2023Open Access
Supplementary Figure 1 from Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells—A Key Role for Heat-Shock Protein 70 and Receptor CD91
2023Open Access
Data from Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells—A Key Role for Heat-Shock Protein 70 and Receptor CD91
2023Open Access
Supplementary Figure legend from Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells—A Key Role for Heat-Shock Protein 70 and Receptor CD91
2023Open Access
Data from Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells—A Key Role for Heat-Shock Protein 70 and Receptor CD91
2023Open Access
Supplementary Figure legend from Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells—A Key Role for Heat-Shock Protein 70 and Receptor CD91
2023Open Access
Data from Expansion of a CD8<sup>+</sup>PD-1<sup>+</sup> Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
2023Open Access
Supplementary Tables 1-2 from Expansion of a CD8<sup>+</sup>PD-1<sup>+</sup> Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
2023Open Access
Data from Expansion of a CD8<sup>+</sup>PD-1<sup>+</sup> Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
2023Open Access
Supplementary Figure 2 from Expansion of a CD8<sup>+</sup>PD-1<sup>+</sup> Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
2023Open Access
Supplementary Figure 2 from Expansion of a CD8<sup>+</sup>PD-1<sup>+</sup> Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
2023Open Access
Supplementary Tables 1-2 from Expansion of a CD8<sup>+</sup>PD-1<sup>+</sup> Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
2023Open Access
Supplementary Figure 3 from Expansion of a CD8<sup>+</sup>PD-1<sup>+</sup> Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
2023Open Access
page 1 of 23Next →

Frequent Co-authors

Nicolas Mottet(12), Thomas Wiegel(12), Silke Gillessen(12), Aled Clayton(12), Theodorus van der Kwast(11), Matthew R. Sydes(11), Mahesh Parmar(11), Erik Briers(9), Ann Henry(9), Thomas Lam(9), Henk G. van der Poel(9), Olivier Rouvière(9), Philip Cornford(9), Nicholas D. James(9), David P. Dearnaley(9), Nicola Fossati(8), Thomas Van den Broeck(8), Ivo G. Schoots(8), Noel W. Clarke(8), A.W.S. Ritchie(8)